Case report: is low α-Gal enzyme activity sufficient to establish the diagnosis of Fabry disease? / Relato de caso: a diminuição da enzimaα-Gal l é suficiente para estabelecer o diagnóstico?
Biagini, Gilson; Almeida, Ana Clara Simões Flórido; Almeida, Tammy Vernalha Rocha; Silva, Cassiano Augusto Braga; Castro, Bruna Fernanda de; Reche, Tais Cristina; Dabinski, Ana Cláudia; Barreto, Fellype Carvalho.
J. bras. nefrol
; 39(3): 333-336, July-Sept. 2017. tab
Artículo
en Inglés
| LILACS | ID: biblio-893763
Abstract Fabry disease is an X-linked lysosomal storage disease due to alpha-galactosidase A (α-Gal A) deficient activity which leads to the accumulation of glucoesphingolipids, such as globotriaosilceramide. There are over 700 known mutations of the enzyme gene, and most of them cause Fabry Disease. This case report describes a hemodialysis patient with a rare and controversial GLA gene mutation, the D313Y. The medecial investigation confirmed that D313Y is an alpha-galactosidase A sequence variant that causes pseudo deficient enzyme activity in plasma but not Fabry disease. Thus, clinical symptoms that prompted Fabry disease investigation could not be attributable to Fabry disease and therefore enzyme replacement therapy was not indicated.
Biblioteca responsable:
BR1.1
Texto completo
Documentos relacionados